Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China flag China · Delayed Price · Currency is CNY
170.61
+0.11 (0.06%)
May 8, 2026, 3:08 PM CST

SHE:300760 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
33,28733,17236,62434,87530,35425,258
Other Revenue
110.11110.11101.6856.6111.8311.73
33,39733,28236,72634,93230,36625,270
Revenue Growth (YoY)
-6.16%-9.38%5.13%15.04%20.17%20.18%
Cost of Revenue
13,62513,52713,76712,76810,9568,967
Gross Profit
19,77219,75522,95922,16419,41016,303
Selling, General & Admin
6,7596,6966,8836,5346,1225,105
Research & Development
3,6143,5793,6663,4332,9232,524
Other Operating Expenses
48.27-13.4-261.66-308.79-80.36-83.14
Operating Expenses
10,52510,45610,5869,9039,0017,539
Operating Income
9,2479,29912,37312,26110,4098,764
Interest Expense
-25.11-24.02-19.41-13-10.69-8.63
Interest & Investment Income
508.82594.86626.87821.64357.91408.14
Currency Exchange Gain (Loss)
-113.43-113.43-51.28119.17171.96-227.66
Other Non Operating Income (Expenses)
-471.6-80.27-87.45-72.51-67.82-85.92
EBT Excluding Unusual Items
9,1469,67612,84213,11710,8608,850
Gain (Loss) on Sale of Investments
1.490.49109.3369.56-26.449.88
Gain (Loss) on Sale of Assets
4.7110.724.242.466.164.07
Asset Writedown
5.6-16.47-1.75-274.92-0.74-7.47
Legal Settlements
-21.38-21.38-14.25-12.65-3.3-5.7
Other Unusual Items
24.9424.9480.25109.68117.5166.78
Pretax Income
9,1619,67413,02013,01110,9549,017
Income Tax Expense
975.631,2221,2801,4331,3431,013
Earnings From Continuing Operations
8,1858,45111,74011,5789,6118,004
Minority Interest in Earnings
-348.61-315.7-71.483.81-3.54-2.49
Net Income
7,8378,13611,66811,5829,6078,002
Net Income to Common
7,8378,13611,66811,5829,6078,002
Net Income Growth
-29.63%-30.28%0.74%20.56%20.07%20.18%
Shares Outstanding (Basic)
1,2121,2121,2111,2121,2101,215
Shares Outstanding (Diluted)
1,2121,2121,2111,2121,2101,215
Shares Change (YoY)
0.03%0.03%-0.04%0.11%-0.36%-0.07%
EPS (Basic)
6.476.719.649.567.946.59
EPS (Diluted)
6.476.719.639.567.946.59
EPS Growth
-29.66%-30.30%0.79%20.42%20.50%20.28%
Free Cash Flow
7,8908,10710,4738,37310,2267,596
Free Cash Flow Per Share
6.516.698.656.918.456.25
Dividend Per Share
4.2204.3806.2705.8004.5003.500
Dividend Growth
-45.05%-30.14%8.10%28.89%28.57%40.00%
Gross Margin
59.20%59.36%62.51%63.45%63.92%64.52%
Operating Margin
27.69%27.94%33.69%35.10%34.28%34.68%
Profit Margin
23.47%24.45%31.77%33.16%31.64%31.66%
Free Cash Flow Margin
23.63%24.36%28.52%23.97%33.67%30.06%
EBITDA
10,85410,85213,71213,15811,1889,380
EBITDA Margin
32.50%32.61%37.34%37.67%36.84%37.12%
D&A For EBITDA
1,6071,5531,339896.04779.11616.47
EBIT
9,2479,29912,37312,26110,4098,764
EBIT Margin
27.69%27.94%33.69%35.10%34.28%34.68%
Effective Tax Rate
10.65%12.64%9.83%11.01%12.26%11.24%
Revenue as Reported
33,39733,28236,72634,93230,36625,270
Advertising Expenses
-303.72332.39359.41288.69223.68
Source: S&P Global Market Intelligence. Standard template. Financial Sources.